Status:
COMPLETED
A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Conditions:
Healthy
Eligibility:
MALE
20-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of clopidogrel and aspirin in free combination as HCP0911.
Eligibility Criteria
Inclusion
- Age between 20 and 55
- Signed informed consent
Exclusion
- Has a history of hypersensitivity to IP ingredients
- Hypotension or hypertension
- Has a history of acute infection within 14days of screening
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01448330
Start Date
July 1 2011
End Date
September 1 2011
Last Update
December 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung medical center
Seoul, South Korea